{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:42Z","timestamp":1792784262953,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Foundation of Natural Science of China","award":["81501085"],"award-info":[{"award-number":["81501085"]}]},{"name":"Clinical Research Program of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["JYLJ202003"],"award-info":[{"award-number":["JYLJ202003"]}],"id":[{"id":"https:\/\/ror.org\/0220qvk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Project of Biobank from Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["YBKB202120"],"award-info":[{"award-number":["YBKB202120"]}],"id":[{"id":"https:\/\/ror.org\/0220qvk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Transverse Research Project of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["JYHX202117002"],"award-info":[{"award-number":["JYHX202117002"]}],"id":[{"id":"https:\/\/ror.org\/0220qvk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Health Management Project of Shanghai Rehabilitation Medical Association","award":["2022KJCX008"],"award-info":[{"award-number":["2022KJCX008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12035-024-04020-y","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T01:02:04Z","timestamp":1708131724000},"page":"7046-7065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-\u03b1-Synuclein: Intranasal LPS Exposure on the A53T-\u03b1-Synuclein Transgenic Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"61","author":[{"given":"Qing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7190-3909","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,17]]},"reference":[{"issue":"5","key":"4020_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/s-0042-1758780","volume":"42","author":"S Rajan","year":"2022","unstructured":"Rajan S, Kaas B (2022) Parkinson\u2019s disease: risk factor modification and prevention. Semin Neurol 42(5):626\u2013638. https:\/\/doi.org\/10.1055\/s-0042-1758780","journal-title":"Semin Neurol"},{"key":"4020_CR2","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2023.0327","author":"G Forloni","year":"2023","unstructured":"Forloni G (2023) Oligomers and neurodegeneration: new evidence. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2023.0327","journal-title":"Aging Dis"},{"issue":"6","key":"4020_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrn3039","volume":"12","author":"TJ Collier","year":"2011","unstructured":"Collier TJ, Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson\u2019s disease: evidence from studies of non-human primates. Nat Rev Neurosci 12(6):359\u2013366. https:\/\/doi.org\/10.1038\/nrn3039","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"4020_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/acel.12312","volume":"14","author":"M Rodriguez","year":"2015","unstructured":"Rodriguez M, Rodriguez-Sabate C, Morales I, Sanchez A, Sabate M (2015) Parkinson\u2019s disease as a result of aging. Aging Cell 14(3):293\u2013308. https:\/\/doi.org\/10.1111\/acel.12312","journal-title":"Aging Cell"},{"issue":"1","key":"4020_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13024-022-00564-6","volume":"17","author":"M Iba","year":"2022","unstructured":"Iba M, McDevitt RA, Kim C, Roy R, Sarantopoulou D, Tommer E, Siegars B, Sallin M et al (2022) Aging exacerbates the brain inflammatory micro-environment contributing to \u03b1-synuclein pathology and functional deficits in a mouse model of DLB\/PD. Mol Neurodegener 17(1):60. https:\/\/doi.org\/10.1186\/s13024-022-00564-6","journal-title":"Mol Neurodegener"},{"key":"4020_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM (2023) Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol 18:95\u2013121. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-034145","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"4020_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1745-7254.2008.00731.x","volume":"29","author":"S Rosner","year":"2008","unstructured":"Rosner S, Giladi N, Orr-Urtreger A (2008) Advances in the genetics of Parkinson\u2019s disease. Acta Pharmacol Sin 29(1):21\u201334. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00731.x","journal-title":"Acta Pharmacol Sin"},{"issue":"5321","key":"4020_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"issue":"6","key":"4020_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1289\/ehp.1003013","volume":"119","author":"HM Gao","year":"2011","unstructured":"Gao HM, Zhang F, Zhou H, Kam W, Wilson B, Hong JS (2011) Neuroinflammation and \u03b1-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson\u2019s disease. Environ Health Perspect 119(6):807\u2013814. https:\/\/doi.org\/10.1289\/ehp.1003013","journal-title":"Environ Health Perspect"},{"issue":"1","key":"4020_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2011.03.005","volume":"94","author":"HM Gao","year":"2011","unstructured":"Gao HM, Hong JS (2011) Gene-environment interactions: key to unraveling the mystery of Parkinson\u2019s disease. Prog Neurobiol 94(1):1\u201319. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.03.005","journal-title":"Prog Neurobiol"},{"issue":"10","key":"4020_CR11","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/jnnp-2020-323646","volume":"91","author":"BM Jacobs","year":"2020","unstructured":"Jacobs BM, Belete D, Bestwick J, Blauwendraat C, Bandres-Ciga S, Heilbron K, Dobson R, Nalls MA et al (2020) Parkinson\u2019s disease determinants, prediction and gene-environment interactions in the UK Biobank. J Neurol Neurosurg Psychiatry 91(10):1046\u20131054. https:\/\/doi.org\/10.1136\/jnnp-2020-323646","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4020_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neubiorev.2019.06.018","volume":"103","author":"AR Dunn","year":"2019","unstructured":"Dunn AR, O\u2019Connell KMS, Kaczorowski CC (2019) Gene-by-environment interactions in Alzheimer\u2019s disease and Parkinson\u2019s disease. Neurosci Biobehav Rev 103:73\u201380. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.06.018","journal-title":"Neurosci Biobehav Rev"},{"key":"4020_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1326-4-34","volume":"4","author":"JP Daher","year":"2009","unstructured":"Daher JP, Ying M, Banerjee R, McDonald RS, Hahn MD, Yang L, Flint Beal M, Thomas B et al (2009) Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons. Mol Neurodegener 4:34. https:\/\/doi.org\/10.1186\/1750-1326-4-34","journal-title":"Mol Neurodegener"},{"issue":"5","key":"4020_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","volume":"66","author":"TM Dawson","year":"2010","unstructured":"Dawson TM, Ko HS, Dawson VL (2010) Genetic animal models of Parkinson\u2019s disease. Neuron 66(5):646\u2013661. https:\/\/doi.org\/10.1016\/j.neuron.2010.04.034","journal-title":"Neuron"},{"key":"4020_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","volume":"54","author":"SM Goldman","year":"2014","unstructured":"Goldman SM (2014) Environmental toxins and Parkinson\u2019s disease. Annu Rev Pharmacol Toxicol 54:141\u2013164. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011613-135937","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"4020_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12974-019-1564-7","volume":"16","author":"GC Brown","year":"2019","unstructured":"Brown GC (2019) The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 16(1):180. https:\/\/doi.org\/10.1186\/s12974-019-1564-7","journal-title":"J Neuroinflammation"},{"issue":"7","key":"4020_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","volume":"279","author":"F Blandini","year":"2012","unstructured":"Blandini F, Armentero MT (2012) Animal models of Parkinson\u2019s disease. Febs j 279(7):1156\u20131166. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08491.x","journal-title":"Febs j"},{"issue":"14","key":"4020_CR18","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/mds.25661","volume":"28","author":"A Haehner","year":"2013","unstructured":"Haehner A, Hummel T, Wolz M, Klingelh\u00f6fer L, Fauser M, Storch A, Reichmann H (2013) Effects of rasagiline on olfactory function in patients with Parkinson\u2019s disease. Mov Disord 28(14):2023\u20132027. https:\/\/doi.org\/10.1002\/mds.25661","journal-title":"Mov Disord"},{"issue":"2","key":"4020_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"4020_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","volume":"1170","author":"CH Hawkes","year":"2009","unstructured":"Hawkes CH, Del Tredici K, Braak H (2009) Parkinson\u2019s disease: the dual hit theory revisited. Ann N Y Acad Sci 1170:615\u2013622. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04365.x","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"4020_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mds.29363","volume":"38","author":"TA Yacoubian","year":"2023","unstructured":"Yacoubian TA, Fang YD, Gerstenecker A, Amara A, Stover N, Ruffrage L, Collette C, Kennedy R et al (2023) Brain and systemic inflammation in de novo Parkinson\u2019s disease. Mov Disord 38(5):743\u2013754. https:\/\/doi.org\/10.1002\/mds.29363","journal-title":"Mov Disord"},{"key":"4020_CR22","doi-asserted-by":"publisher","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G (2020) Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease. Int J Mol Sci 21(22):8421. https:\/\/doi.org\/10.3390\/ijms21228421","DOI":"10.3390\/ijms21228421"},{"issue":"7","key":"4020_CR23","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, Rojo AI, Manda G, Bosc\u00e1 L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9(7):1687. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"key":"4020_CR24","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3389\/fimmu.2018.02527","volume":"9","author":"B Huang","year":"2018","unstructured":"Huang B, Liu J, Meng T, Li Y, He D, Ran X, Chen G et al (2018) Polydatin prevents lipopolysaccharide (LPS)-induced Parkinson\u2019s disease via regulation of the AKT\/GSK3\u03b2-Nrf2\/NF-\u03baB signaling axis. Front Immunol 9:2527. https:\/\/doi.org\/10.3389\/fimmu.2018.02527","journal-title":"Front Immunol"},{"key":"4020_CR25","doi-asserted-by":"publisher","first-page":"104814","DOI":"10.1016\/j.nbd.2020.104814","volume":"140","author":"L Yang","year":"2020","unstructured":"Yang L, Zhou R, Tong Y, Chen P, Shen Y, Miao S, Liu X (2020) Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation. Neurobiol Dis 140:104814. https:\/\/doi.org\/10.1016\/j.nbd.2020.104814","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4020_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-022-00544-w","volume":"17","author":"M Al-Nusaif","year":"2022","unstructured":"Al-Nusaif M, Yang Y, Li S, Cheng C, Le W (2022) The role of NURR1 in metabolic abnormalities of Parkinson\u2019s disease. Mol Neurodegener 17(1):46. https:\/\/doi.org\/10.1186\/s13024-022-00544-w","journal-title":"Mol Neurodegener"},{"key":"4020_CR27","doi-asserted-by":"publisher","unstructured":"Gao H, Wang D, Jiang S, Mao J, Yang X (2021) NF\u2011\u03baB is negatively associated with Nurr1 to reduce the inflammatory response in Parkinson\u2019s disease. Mol Med Rep 23(6):396. https:\/\/doi.org\/10.3892\/mmr.2021.12035","DOI":"10.3892\/mmr.2021.12035"},{"issue":"11","key":"4020_CR28","doi-asserted-by":"publisher","first-page":"e78418","DOI":"10.1371\/journal.pone.0078418","volume":"8","author":"Q He","year":"2013","unstructured":"He Q, Yu W, Wu J, Chen C, Lou Z, Zhang Q, Zhao J, Wang J, Xiao B (2013) Intranasal LPS-mediated Parkinson\u2019s model challenges the pathogenesis of nasal cavity and environmental toxins. PLoS ONE 8(11):e78418. https:\/\/doi.org\/10.1371\/journal.pone.0078418","journal-title":"PLoS ONE"},{"issue":"3","key":"4020_CR29","doi-asserted-by":"publisher","first-page":"e0119928","DOI":"10.1371\/journal.pone.0119928","volume":"10","author":"S Zhang","year":"2015","unstructured":"Zhang S, Xiao Q, Le W (2015) Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant \u03b1-synuclein. PLoS ONE 10(3):e0119928. https:\/\/doi.org\/10.1371\/journal.pone.0119928","journal-title":"PLoS ONE"},{"key":"4020_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuint.2018.04.003","volume":"118","author":"PV Bhat","year":"2018","unstructured":"Bhat PV, Anand T, Mohan Manu T, Khanum F (2018) Restorative effect of l-Dopa treatment against ochratoxin A induced neurotoxicity. Neurochem Int 118:252\u2013263. https:\/\/doi.org\/10.1016\/j.neuint.2018.04.003","journal-title":"Neurochem Int"},{"issue":"7","key":"4020_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jamaneurol.2021.0863","volume":"78","author":"ER Dorsey","year":"2021","unstructured":"Dorsey ER, Okun MS, Tanner CM (2021) Bad air and Parkinson disease-the fog may be lifting. JAMA Neurol 78(7):793\u2013795. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0863","journal-title":"JAMA Neurol"},{"issue":"2","key":"4020_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00004647-200202000-00011","volume":"22","author":"V Sossi","year":"2002","unstructured":"Sossi V, de La Fuente-Fern\u00e1ndez R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, Ruth TJ (2002) Increase in dopamine turnover occurs early in Parkinson\u2019s disease: evidence from a new modeling approach to PET 18 F-fluorodopa data. J Cereb Blood Flow Metab 22(2):232\u2013239. https:\/\/doi.org\/10.1097\/00004647-200202000-00011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"4020_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/clpt.2010.138","volume":"88","author":"MP Horowitz","year":"2010","unstructured":"Horowitz MP, Greenamyre JT (2010) Gene-environment interactions in Parkinson\u2019s disease: the importance of animal modeling. Clin Pharmacol Ther 88(4):467\u2013474. https:\/\/doi.org\/10.1038\/clpt.2010.138","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4020_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28411","volume":"36","author":"EM Kline","year":"2021","unstructured":"Kline EM, Houser MC, Herrick MK, Seibler P, Klein C, West A, Tansey MG (2021) Genetic and environmental factors in Parkinson\u2019s disease converge on immune function and inflammation. Mov Disord 36(1):25\u201336. https:\/\/doi.org\/10.1002\/mds.28411","journal-title":"Mov Disord"},{"key":"4020_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","volume":"10","author":"E Caggiu","year":"2019","unstructured":"Caggiu E, Arru G, Hosseini S, Niegowska M, Sechi G, Zarbo IR, Sechi LA (2019) Inflammation, infectious triggers, and Parkinson\u2019s disease. Front Neurol 10:122. https:\/\/doi.org\/10.3389\/fneur.2019.00122","journal-title":"Front Neurol"},{"issue":"11","key":"4020_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"4020_CR37","doi-asserted-by":"publisher","first-page":"782462","DOI":"10.1155\/2012\/782462","volume":"2012","author":"S Genc","year":"2012","unstructured":"Genc S, Zadeoglulari Z, Fuss SH, Genc K (2012) The adverse effects of air pollution on the nervous system. J Toxicol 2012:782462. https:\/\/doi.org\/10.1155\/2012\/782462","journal-title":"J Toxicol"},{"issue":"16","key":"4020_CR38","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1523\/jneurosci.20-16-06309.2000","volume":"20","author":"WG Kim","year":"2000","unstructured":"Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20(16):6309\u20136316. https:\/\/doi.org\/10.1523\/jneurosci.20-16-06309.2000","journal-title":"J Neurosci"},{"issue":"1","key":"4020_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ejn.13132","volume":"43","author":"Q He","year":"2016","unstructured":"He Q, Li YH, Guo SS, Wang Y, Lin W, Zhang Q, Wang J, Ma CG, Xiao BG (2016) Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson\u2019s model. Eur J Neurosci 43(1):41\u201352. https:\/\/doi.org\/10.1111\/ejn.13132","journal-title":"Eur J Neurosci"},{"issue":"8","key":"4020_CR40","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150(8):963\u2013976. https:\/\/doi.org\/10.1038\/sj.bjp.0707167","journal-title":"Br J Pharmacol"},{"issue":"4","key":"4020_CR41","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1007\/s11033-021-06343-8","volume":"48","author":"H Gao","year":"2021","unstructured":"Gao H, Wang D, Wang YL, Mao JP, Jiang S, Yang XL (2021) Pramipexole attenuates 6-OHDA-induced Parkinson\u2019s disease by mediating the Nurr1\/NF-\u03baB pathway. Mol Biol Rep 48(4):3079\u20133087. https:\/\/doi.org\/10.1007\/s11033-021-06343-8","journal-title":"Mol Biol Rep"},{"issue":"Pt B","key":"4020_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109(Pt B):249\u2013257. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.004","journal-title":"Neurobiol Dis"},{"issue":"6","key":"4020_CR43","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918\u2013934. https:\/\/doi.org\/10.1016\/j.cell.2010.02.016","journal-title":"Cell"},{"issue":"1","key":"4020_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12974-023-02720-1","volume":"20","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Tong Q, Yuan Y, Song X, Jiang W, Wang Y, Li W, Li Y, Zhang K (2023) \u03b1-Synuclein induces prodromal symptoms of Parkinson\u2019s disease via activating TLR2\/MyD88\/NF-\u03baB pathway in Schwann cells of vagus nerve in a rat model. J Neuroinflammation 20(1):36. https:\/\/doi.org\/10.1186\/s12974-023-02720-1","journal-title":"J Neuroinflammation"},{"issue":"3","key":"4020_CR45","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bpa.12370","volume":"26","author":"A Atik","year":"2016","unstructured":"Atik A, Stewart T, Zhang J (2016) Alpha-synuclein as a biomarker for Parkinson\u2019s disease. Brain Pathol 26(3):410\u2013418. https:\/\/doi.org\/10.1111\/bpa.12370","journal-title":"Brain Pathol"},{"issue":"6","key":"4020_CR46","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/bpa.12886","volume":"30","author":"H Niu","year":"2020","unstructured":"Niu H, Wang Q, Zhao W, Liu J, Wang D, Muhammad B, Liu X, Quan N, Zhang H, Zhang F, Wang Y, Li H, Yang R (2020) IL-1\u03b2\/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-synuclein pathology in the olfactory bulb, substantia nigra and striatum. Brain Pathol 30(6):1102\u20131118. https:\/\/doi.org\/10.1111\/bpa.12886","journal-title":"Brain Pathol"},{"issue":"16","key":"4020_CR47","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/hmg\/ddab118","volume":"30","author":"M Argyrofthalmidou","year":"2021","unstructured":"Argyrofthalmidou M, Spathis AD, Maniati M, Poula A, Katsianou MA, Sotiriou E, Manousaki M, Perier C, Papapanagiotou I, Papadopoulou-Daifoti Z, Pitychoutis PM, Alexakos P, Vila M, Stefanis L, Vassilatis DK (2021) Nurr1 repression mediates cardinal features of Parkinson\u2019s disease in \u03b1-synuclein transgenic mice. Hum Mol Genet 30(16):1469\u20131483. https:\/\/doi.org\/10.1093\/hmg\/ddab118","journal-title":"Hum Mol Genet"},{"key":"4020_CR48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fnmol.2020.00064","volume":"13","author":"C Jia","year":"2020","unstructured":"Jia C, Qi H, Cheng C, Wu X, Yang Z, Cai H, Chen S, Le W (2020) \u03b1-Synuclein negatively regulates Nurr1 expression through NF-\u03baB-Related mechanism. Front Mol Neurosci 13:64. https:\/\/doi.org\/10.3389\/fnmol.2020.00064","journal-title":"Front Mol Neurosci"},{"issue":"27","key":"4020_CR49","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.1523\/jneurosci.1731-12.2012","volume":"32","author":"X Lin","year":"2012","unstructured":"Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, Sun L, Shim H, Gu XL, Luo J, Long CX, Ding J, Mateo Y, Sullivan PH, Wu LG, Goldstein DS, Lovinger D, Cai H (2012) Conditional expression of Parkinson\u2019s disease-related mutant \u03b1-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J Neurosci 32(27):9248\u20139264. https:\/\/doi.org\/10.1523\/jneurosci.1731-12.2012","journal-title":"J Neurosci"},{"issue":"163","key":"4020_CR50","doi-asserted-by":"publisher","first-page":"163ra156","DOI":"10.1126\/scitranslmed.3004676","volume":"4","author":"M Decressac","year":"2012","unstructured":"Decressac M, Kadkhodaei B, Mattsson B, Laguna A, Perlmann T, Bj\u00f6rklund A (2012) \u03b1-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons. Sci Transl Med 4(163):163ra156. https:\/\/doi.org\/10.1126\/scitranslmed.3004676","journal-title":"Sci Transl Med"},{"issue":"4","key":"4020_CR51","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/biom5042675","volume":"5","author":"W Bobela","year":"2015","unstructured":"Bobela W, Aebischer P, Schneider BL (2015) \u0391lpha-synuclein as a mediator in the interplay between aging and Parkinson\u2019s disease. Biomolecules 5(4):2675\u20132700. https:\/\/doi.org\/10.3390\/biom5042675","journal-title":"Biomolecules"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04020-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T12:20:56Z","timestamp":1724329256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04020-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,17]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4020"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04020-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,17]]},"assertion":[{"value":"15 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shanghai Ninth People\u2019s Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, China. All experiments were conducted in accordance with the guidelines of the International Council for Laboratory Animal Science.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors have reviewed the final manuscript and have given their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}